BioAlliance Pharma Announces the Initiation of the Phase II Clinical Trial with Validive® in the United States PARIS--(BUSINESS WIRE)--Regulatory News : BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a Company dedicated to the development of orphan oncology products and supportive care products, announces the initiation of its Phase II clinical trial evaluating the efficacy and safety of Validive® (clonidine Lauriad®) in the United States in patients with chemoradiation therapy-induced oral ...
June 10, 2013 - Business Wire
Sam Kelley in Boston Herald Clonidine can be a dangerous medication. If used properly, it can be very safe, but too much of it can be dangerous,said Sam Kelley, a Cohasset psychiatrist and medical director of the Massachusetts Society for the Prevention of Cruelty to...